IRIS
MAZZARINO, Maria Clorinda
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.670
AS - Asia 2.020
EU - Europa 1.985
SA - Sud America 382
AF - Africa 272
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 10.340
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.492
SG - Singapore 1.105
RU - Federazione Russa 729
CN - Cina 655
UA - Ucraina 413
IE - Irlanda 366
BR - Brasile 332
CI - Costa d'Avorio 187
IT - Italia 185
CA - Canada 154
DE - Germania 75
VN - Vietnam 73
SE - Svezia 64
GB - Regno Unito 44
IN - India 44
SN - Senegal 44
AR - Argentina 22
PL - Polonia 22
MX - Messico 20
ZA - Sudafrica 19
HK - Hong Kong 18
IQ - Iraq 15
NL - Olanda 15
BD - Bangladesh 14
CH - Svizzera 14
FR - Francia 14
IR - Iran 14
ID - Indonesia 11
KR - Corea 11
TR - Turchia 11
UZ - Uzbekistan 11
AT - Austria 10
CO - Colombia 10
EC - Ecuador 9
JP - Giappone 9
MA - Marocco 8
EU - Europa 7
ES - Italia 6
GR - Grecia 6
BE - Belgio 4
BG - Bulgaria 4
FI - Finlandia 4
KE - Kenya 4
MY - Malesia 4
AE - Emirati Arabi Uniti 3
LT - Lituania 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
LB - Libano 2
OM - Oman 2
PH - Filippine 2
PK - Pakistan 2
SA - Arabia Saudita 2
UY - Uruguay 2
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CD - Congo 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 10.340
Salva come PNG Salva come JPEG
Città #
Dallas 1.117
Santa Clara 673
Singapore 642
Jacksonville 494
Chandler 405
Dublin 367
Moscow 317
Houston 316
Chicago 223
Abidjan 187
Boardman 180
Ashburn 170
San Jose 133
Nanjing 117
Beijing 116
Toronto 112
Cambridge 108
Lawrence 107
Andover 106
Los Angeles 87
Des Moines 78
San Mateo 67
Catania 65
Hefei 51
Grafing 47
Wilmington 46
Dakar 44
Hebei 35
Nanchang 35
Buffalo 34
New York 34
Saint Petersburg 30
The Dalles 27
São Paulo 26
Columbus 25
Jiaxing 25
Ho Chi Minh City 24
Council Bluffs 22
Shenyang 22
Civitanova Marche 19
San Francisco 19
Orem 17
Tianjin 17
Changsha 16
Hong Kong 16
Florence 15
Ottawa 15
Warsaw 15
Boston 14
Chennai 14
Ardabil 13
Johannesburg 13
Leawood 13
Rio de Janeiro 13
Augusta 12
Brooklyn 12
Hanoi 12
Montreal 12
Stockholm 12
Atlanta 11
Bremen 11
London 11
Amsterdam 10
Denver 10
Kunming 10
Norwalk 10
Seattle 10
Seoul 10
Monmouth Junction 9
Tokyo 9
Baghdad 8
Hangzhou 8
Mumbai 8
Ningbo 8
Porto Alegre 8
Jinan 7
Mexico City 7
Curitiba 6
Falls Church 6
Redondo Beach 6
Ankara 5
Belo Horizonte 5
Campinas 5
Goiânia 5
Guangzhou 5
Misterbianco 5
Tashkent 5
Brasília 4
Brussels 4
Caxias do Sul 4
Dearborn 4
Den Haag 4
Haiphong 4
Jakarta 4
Joinville 4
Kiev 4
Manchester 4
Milan 4
Phoenix 4
Poplar 4
Totale 7.273
Salva come PNG Salva come JPEG
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 399
The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance 317
Advances in targeting signal transduction pathways. 225
Absence of BRAF gene mutation in non-melanoma skin tumors 202
All trans retinoic acid sensitizes colon cancer cells to hyperthermia cytotoxic effects 159
Analysis of hepatitis C virus infection among health-care workers: an observational study 158
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features 152
Analysis of BRAF mutation in primary and metastatic melanoma 147
Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression 147
Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients 147
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene 144
Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus 143
Analysis of G(-174) CIL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease 142
Beta-2-glycoprotein I is growth regulated and plays a role as survival factor for hepatocytes 141
Association of TIMP-1 +372 SNP with digital ulcer manifestation in female systemic sclerosis patients 133
B-cell neoplasia in the context of HCV infection: A distinct entity? 130
BRAF G469S mutation as indicator of neoplastic transformation in workers with UV exposure 128
Analysis of MMP-9 gene polymorphism 1562C/T in patients suffering from systemic sclerosis with and without ulcers 124
Proinflammatory circulating molecules in peripheral arterial disease 123
Detection of BRAF gene mutation in primary choroidal melanoma tissue 121
Analysis of matrix metalloproteinase-9 gene polymorphism-1562 C/T in patients suffering from systemic sclerosis with and without ulcers 121
Co-regulated expression of matrix metalloproteinase-2 and transforming growth factor-beta in melanoma development and progression 120
Analysis of osteopontin and matrix metalloproteinase-9 in prostate cancer 119
Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients 118
Behavior of complement and anti-complement factors in the course of hepatic regeneration and degeneration 113
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 109
Soluble adhesion molecules and cytokines in children affected by recurrent infections of the upper respiratory tract 106
CD155/Neel-5 immunolocallization in melanocytic skin lesions 106
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection 103
Biologically induced improvement of PASI score is associated with a decline of S100A7 expression in psoriatic skin lesions. A preliminary immunohistochemical study 101
Defective function of the fas apoptotic pathway in type 1 diabetes mellitus correlates with age at onset 99
Vitamin D3: an ever green molecule 99
Biological therapy induces expression changes in Notch pathway in psoriasis 98
Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients 97
Contribution of Immunohistochemistry in Revealing S100A7/JAB1 Colocalization in Psoriatic Epidermal Keratinocyte 96
S100A7, Jab1, and p27 kip1 expression in psoriasis and S100A7 CRISPR-activated human keratinocyte cell line 95
Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to alpha-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study 94
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease 94
Role of Hypoxia and Autophagy in MDA-MB-231 Invasiveness 94
IL-2 RECEPTORS, NK AND LAK CYTOTOXICITY OF LYMPHOCYTES IN BREAST-CARCINOMA DURING PROLONGED THYMOPENTIN THERAPY 92
S100A7: A rAMPing up AMP molecule in psoriasis 92
CD155/Necl-5 immunolocalization in melanocytic skin lesions 91
IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age 90
Computational Evaluation of Yin Yang 1 Transcript Levels in the Spectrum of B-cell Neoplasia 90
GIT-27 NO may be a potential therapeutic agent for melanoma treatment by inhibition of the transcription repressor YIN-YANG 89
IL2 and its receptors in elderly subjects on hemodialysis 89
Effect of alpha-interferon on natural killer cell activity and lymphocyte subsets in thalassemia patients with chronic hepatitis C 88
Jagged-1 expression is downregulated in skin from biologic-treated psoriatic patients 87
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 87
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 87
Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation 87
Role of BRAF mutations in hematopoietic malignancies and the induction of cytokine-independence-synergy with PI3K/Akt pathway 86
Evaluation of circulating CD4⁺CD25⁺ and liver-infiltrating Foxp3⁺ cells in HCV-associated liver disease 86
Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease 85
Sensitization of cancer stem cells based on inhibiting key signal transduction pathways 85
FOXP3, ICOS and ICOSL gene polymorphisms in systemic sclerosis: FOXP3 rs2294020 is associated with disease progression in a female Italian population 85
IL-18 nelle infezioni virali ricorrenti in età pediatrica 84
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression 84
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance 84
Persistent high plasma levels of interleukins 18 and 4 in children with recurrent infections of the upper respiratory tract 83
Obesity, Type 1 Diabetes, and Psoriasis: An Autoimmune Triple Flip 82
High circulating levels of cytockines (IL6 and TNFα), adhesion molecules (VICAM-1 and ICAM-1) and selectines in patients with peripheral arterial disease at rest and after a treadmill-test 81
Isoproterenol modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) in rat parotid gland 81
Rituximab for treatment of lymphoproliferative disorders associated with hepatitis C virus (HCV) infection 81
Regulation of drug and immune resistance by YY1 in cancer 80
Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis 79
Genetic polymorphisms of FOXP3 in Italian patients with systemic sclerosis 77
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 77
Expression and localization of prominin-1 in isoproterenol-treated rat parotid gland 77
Jagged-1/Notch-1/Hes-1 pathway in psoriatic patients: effects of biological therapy 77
Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells 77
Long pentraxin 3: a marker of inflammation in untreated psoriatic patients 76
Insight into the role of microRNAs in brain tumors (review) 76
CIRCULATING IMMUNOCOMPLEXES AND LARYNGEAL CARCINOMA 76
Effects of ischaemic stress on leukocyte activation processes in patients with chronic peripheral occlusive arterial disease: Role of L-propionyl carnitine administration 76
Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer 75
Isoproterenol treatment modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) expression in rat parotid gland 75
High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation 74
Immunohistocemical localization of NECL-5 in melanocytic skin lesions. Preliminary observations 74
Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer 73
Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway 73
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health 73
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappa B inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes 72
Novel NO-donating compound GIT-27NO possesses strong tumoricidal capacity in vitro and in vivo 72
Effects of adalimumab, etanercept and ustekinumab on the expression of psoriasin (S100A7) in psoriatic skin 72
Uterine cervical carcinoma: Role of matrix metalloproteinases (Review) 71
Modulation of Chitotriosidase During Macrophage Differentiation 71
MAPK and AKT pathways are activated in melanoma by BRAF, NRAS and PIK3CA mutations 71
Preoperative rIL-2 treatment in renal cancer: Early and late effects on lymphocyte subsets and proliferation, NK activity, IL-6 in vivo and in vitro production 70
S100A7 in psoriasis: Immunodetection and activation by CRISPR technology 69
Immunolocalization of FOXP3 in HCV-infected liver biopsies. Preliminary observations 68
Frequency of bcl-2/IgH translocation in patients with non-Hodgkin's lymphoma and chronic hepatitis C virus infection 67
Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection 66
Prognostic significance of YY1 in High Grade Lymphomas 66
Osteopontin and matrix metalloptroteinase-9 as markers of early detection of prostate cancer development 65
Venous stasis causes release of interleukin 1β (IL - 1β), interleukin 6 (IL – 6) and tumor necrosis factor alpha (TNFα) by monocite macrophage 65
Lack of association of rs3761549 and rs5902434 polymorphisms of FOXP3 gene with risk of systemic sclerosis in the Italian population: A case-control study 65
Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barre syndrome 63
Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma 58
Understanding rituximab function and resistance: implications for tailored therapy 57
Totale 10.093
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.492
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021403 0 0 0 0 0 0 97 0 105 0 179 22
2021/2022793 102 107 0 8 126 6 113 24 75 0 15 217
2022/20231.167 117 53 20 105 124 212 2 202 269 12 40 11
2023/2024500 22 75 22 42 11 122 1 51 9 7 85 53
2024/20252.170 21 446 100 49 499 282 30 81 186 179 144 153
2025/20263.663 296 340 1.064 322 696 812 133 0 0 0 0 0
Totale 10.474